Search - tctmd.com

Displaying 901 - 920 of 978

Sort: Relevancy | Date

Presentation TCT 2012

FFR Decision-Making in a Patient with Left Main Disease and Atrial Septal Defect

Presenter: Naoto Inoue

October 25, 2012

Presentation TCT 2012

CT for Preventing and Predicting TAVR-Associated Complications

Presenter: James Min

October 25, 2012

Presentation TCT 2012

Correlation Between FFR and iFR: An Independent Validation Study

Presenter: Nils Johnson

October 25, 2012

Presentation TCT 2012

Coronary Physiology and FFR

Presenter: William Fearon

October 25, 2012

Presentation TCT 2012

Case 5: FFR in Tandem Lesions

Presenter: Nico Pijls

October 25, 2012

Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

October 24, 2012

Presentation TCT 2012

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

Presenter: Bon-Kwon Koo

October 24, 2012

Presentation TCT 2012

Lessons from FAME II

Presenter: Stuart Pocock

October 24, 2012

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Presenter: Tim van de Hoef

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Presenter: Michael Lim

October 23, 2012

Presentation TCT 2012

Use and Utility of FFR During Left Main Stenting

Presenter: Seung-Jung Park

October 22, 2012

Presentation TCT 2012

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Presenter: Anupam Bhambhani

October 22, 2012

Presentation TCT 2012

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

Presenter: Allen Jeremias

October 22, 2012

Presentation TCT 2012

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Presenter: Soo-Jin Kang

October 22, 2012

Presentation TCT 2012

Left Main PCI: Integrated Use of FFR and IVUS

Presenter: Gary Mintz

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

Presentation TCT 2012

Complex Left Main PCI with FFR at Multiple Steps

Presenter: William Fearon

October 22, 2012

Advertisement

FFR Decision-Making in a Patient with Left Main Disease and Atrial Septal Defect

CT for Preventing and Predicting TAVR-Associated Complications

Correlation Between FFR and iFR: An Independent Validation Study

Coronary Physiology and FFR

Case 5: FFR in Tandem Lesions

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

Lessons from FAME II

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Use and Utility of FFR During Left Main Stenting

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Left Main PCI: Integrated Use of FFR and IVUS

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Complex Left Main PCI with FFR at Multiple Steps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content